Format
Sort by
Items per page

Send to

Choose Destination

Best matches for body weight decreased AND lifestyle changes AND obesity AND pharmacotherapy:

Search results

Items: 1 to 20 of 56

1.

A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity.

Erickson ZD, Kwan CL, Gelberg HA, Arnold IY, Chamberlin V, Rosen JA, Shah C, Nguyen CT, Hellemann G, Aragaki DR, Kunkel CF, Lewis MM, Sachinvala N, Sonza PA, Pierre JM, Ames D.

J Gen Intern Med. 2017 Apr;32(Suppl 1):32-39. doi: 10.1007/s11606-016-3960-3.

2.

UP601, a standardized botanical composition composed of Morus alba, Yerba mate and Magnolia officinalis for weight loss.

Yimam M, Jiao P, Hong M, Brownell L, Lee YC, Hyun EJ, Kim HJ, Nam JB, Kim MR, Jia Q.

BMC Complement Altern Med. 2017 Feb 16;17(1):114. doi: 10.1186/s12906-017-1627-1.

3.

Modulatory effect of vanillic acid on antioxidant status in high fat diet-induced changes in diabetic hypertensive rats.

Vinothiya K, Ashokkumar N.

Biomed Pharmacother. 2017 Mar;87:640-652. doi: 10.1016/j.biopha.2016.12.134. Epub 2017 Jan 11.

PMID:
28088113
4.

Gastrojejunal anastomotic reduction for weight regain in roux-en-y gastric bypass patients: physiological, behavioral, and anatomical effects of endoscopic suturing and sclerotherapy.

Jirapinyo P, Dayyeh BK, Thompson CC.

Surg Obes Relat Dis. 2016 Dec;12(10):1810-1816. doi: 10.1016/j.soard.2016.09.036. Epub 2016 Oct 4.

5.

Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials.

He L, Liu X, Wang L, Yang Z.

Medicine (Baltimore). 2016 Oct;95(42):e4947. Review.

6.

Effect of a Modest Weight Loss in Normalizing Blood Pressure in Obese Subjects on Antihypertensive Drugs.

Gilardini L, Redaelli G, Croci M, Conti A, Pasqualinotto L, Invitti C.

Obes Facts. 2016;9(4):251-8. doi: 10.1159/000445504. Epub 2016 Jul 26.

7.
8.

Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.

Xiao DY, Luo S, O'Brian K, Sanfilippo KM, Ganti A, Riedell P, Lynch RC, Liu W, Kahl BS, Cashen AF, Fehniger TA, Carson KR.

J Natl Cancer Inst. 2016 Jul 5;108(11). doi: 10.1093/jnci/djw145. Print 2016 Nov.

9.

Flaxseed Supplementation in Metabolic Syndrome Management: A Pilot Randomized, Open-labeled, Controlled Study.

Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A.

Phytother Res. 2016 Aug;30(8):1339-44. doi: 10.1002/ptr.5635. Epub 2016 May 6.

PMID:
27151322
10.

Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy.

Yamamoto C, Miyoshi H, Ono K, Sugawara H, Kameda R, Ichiyama M, Yamamoto K, Nomoto H, Nakamura A, Atsumi T.

Endocr J. 2016 Jun 30;63(6):589-96. doi: 10.1507/endocrj.EJ15-0749. Epub 2016 Apr 6.

11.

Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction.

Trivedi VR, Satia MC, Deschamps A, Maquet V, Shah RB, Zinzuwadia PH, Trivedi JV.

Nutr J. 2016 Jan 8;15:3. doi: 10.1186/s12937-016-0122-8.

12.

Effects of weight loss diet therapy on anthropometric measurements and biochemical variables in schizophrenic patients.

Urhan M, Ergün C, Aksoy M, Ayer A.

Nord J Psychiatry. 2015 Jul;69(5):323-30. doi: 10.3109/08039488.2014.981288. Epub 2015 May 18.

PMID:
25981354
13.

Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.

Nguyen KT, Billington CJ, Vella A, Wang Q, Ahmed L, Bantle JP, Bessler M, Connett JE, Inabnet WB, Thomas A, Ikramuddin S, Korner J.

Diabetes. 2015 Sep;64(9):3104-10. doi: 10.2337/db14-1870. Epub 2015 Apr 21.

14.

Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S.

Diabet Med. 2015 Dec;32(12):1611-6. doi: 10.1111/dme.12776. Epub 2015 May 8.

PMID:
25864699
15.

Effects of metformin on energy intake and satiety in obese children.

Adeyemo MA, McDuffie JR, Kozlosky M, Krakoff J, Calis KA, Brady SM, Yanovski JA.

Diabetes Obes Metab. 2015 Apr;17(4):363-70. doi: 10.1111/dom.12426. Epub 2015 Jan 11.

16.

Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P.

J Am Coll Cardiol. 2014 Dec 2;64(21):2222-31. doi: 10.1016/j.jacc.2014.09.028. Epub 2014 Nov 24.

17.

The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.

McDonnell DP, Chang CY, Nelson ER.

Climacteric. 2014 Dec;17 Suppl 2:60-5. doi: 10.3109/13697137.2014.966949. Epub 2014 Oct 16.

18.

Effect of fat loss on arterial elasticity in obese adolescents with clinical insulin resistance: RESIST study.

Ho M, Gow M, Baur LA, Benitez-Aguirre PZ, Tam CS, Donaghue KC, Craig ME, Cowell CT, Garnett SP.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1846-53. doi: 10.1210/jc.2014-1944. Epub 2014 Jun 23.

PMID:
24955610
19.

Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors.

Gutiérrez-Salmeán G, Ortiz-Vilchis P, Vacaseydel CM, Garduño-Siciliano L, Chamorro-Cevallos G, Meaney E, Villafaña S, Villarreal F, Ceballos G, Ramírez-Sánchez I.

Eur J Pharmacol. 2014 Apr 5;728:24-30. doi: 10.1016/j.ejphar.2014.01.053. Epub 2014 Jan 31.

PMID:
24491839
20.

Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention.

Uysal Y, Wolters B, Knop C, Reinehr T.

Clin Nutr. 2014 Aug;33(4):620-5. doi: 10.1016/j.clnu.2013.09.007. Epub 2013 Sep 18.

PMID:
24075648

Supplemental Content

Loading ...
Support Center